Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort

INTRODUCTION: Several clinical studies have reported the efficacy of favipiravir in reducing viral load and shortening the duration of symptoms. However, the viability of SARS-CoV-2 in the context of favipiravir therapy and the potential for resistance development is unclear. METHODS: We sequenced S...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Chemother
Autors principals: Suzuki, Masahiro, Imai, Takumi, Sakurai, Aki, Komoto, Satoshi, Ide, Tomihiko, Lim, Chang Kweng, Shintani, Ayumi, Doi, Yohei, Murata, Takayuki
Format: Artigo
Idioma:Inglês
Publicat: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8196299/
https://ncbi.nlm.nih.gov/pubmed/34176716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiac.2021.06.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars